A detailed history of Wells Fargo & Company transactions in Natera, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 55,796 shares of NTRA stock, worth $9.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,796
Previous 53,829 3.65%
Holding current value
$9.39 Million
Previous $5.83 Million 21.65%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$97.75 - $129.67 $192,274 - $255,060
1,967 Added 3.65%
55,796 $7.09 Million
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $1.61 Million - $2.12 Million
18,851 Added 53.89%
53,829 $5.83 Million
Q1 2024

May 10, 2024

BUY
$59.21 - $92.9 $929,893 - $1.46 Million
15,705 Added 81.49%
34,978 $3.2 Million
Q4 2023

Feb 09, 2024

SELL
$37.55 - $62.64 $1.13 Million - $1.89 Million
-30,146 Reduced 61.0%
19,273 $1.21 Million
Q3 2023

Nov 13, 2023

SELL
$43.4 - $62.52 $860,144 - $1.24 Million
-19,819 Reduced 28.62%
49,419 $2.19 Million
Q2 2023

Aug 15, 2023

BUY
$47.08 - $55.16 $1.72 Million - $2.01 Million
36,448 Added 111.16%
69,238 $3.37 Million
Q1 2023

May 12, 2023

BUY
$36.57 - $58.29 $926,098 - $1.48 Million
25,324 Added 339.19%
32,790 $1.82 Million
Q4 2022

Feb 13, 2023

SELL
$34.17 - $47.91 $1.8 Million - $2.52 Million
-52,582 Reduced 87.57%
7,466 $299,000
Q3 2022

Nov 14, 2022

SELL
$36.93 - $56.68 $46,310 - $71,076
-1,254 Reduced 2.05%
60,048 $2.63 Million
Q2 2022

Aug 12, 2022

SELL
$28.13 - $44.54 $567,635 - $898,772
-20,179 Reduced 24.77%
61,302 $2.17 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $6.22 Million - $18.7 Million
-205,260 Reduced 71.58%
81,481 $3.32 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $341 Million - $471 Million
-3,955,553 Reduced 93.24%
286,741 $26.8 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $19.5 Million - $24.6 Million
194,405 Added 4.8%
4,242,294 $473 Million
Q2 2021

Aug 16, 2021

BUY
$86.05 - $119.72 $33.5 Million - $46.6 Million
388,979 Added 10.63%
4,047,889 $460 Million
Q1 2021

May 13, 2021

BUY
$91.47 - $124.36 $40.7 Million - $55.3 Million
444,869 Added 13.84%
3,658,910 $372 Million
Q4 2020

Feb 09, 2021

SELL
$66.66 - $111.74 $3.95 Million - $6.61 Million
-59,192 Reduced 1.81%
3,214,041 $320 Million
Q3 2020

Nov 05, 2020

BUY
$45.89 - $72.67 $1.24 Million - $1.96 Million
26,914 Added 0.83%
3,273,233 $236 Million
Q2 2020

Aug 13, 2020

BUY
$26.36 - $49.86 $7.91 Million - $15 Million
300,012 Added 10.18%
3,246,319 $162 Million
Q1 2020

May 14, 2020

BUY
$17.27 - $40.17 $50.9 Million - $118 Million
2,946,307 New
2,946,307 $88 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.